• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国轻度缺血性卒中的再灌注治疗频率和结局。

Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States.

机构信息

Division of Interventional Neuroradiology, Department of Radiological Sciences (H.S., K.K., V.S., S.T., G.P.C., M.N., R.J., G.D.), University of California, Los Angeles (UCLA).

Department of Neurosurgery (G.P.C.), University of California, Los Angeles (UCLA).

出版信息

Stroke. 2020 Nov;51(11):3241-3249. doi: 10.1161/STROKEAHA.120.030898. Epub 2020 Oct 21.

DOI:10.1161/STROKEAHA.120.030898
PMID:33081604
Abstract

BACKGROUND AND PURPOSE

More than half of patients with acute ischemic stroke have minor neurological deficits; however, the frequency and outcomes of reperfusion therapy in regular practice has not been well-delineated.

METHODS

Analysis of US National Inpatient Sample of hospitalizations with acute ischemic stroke and mild deficits (National Institutes of Health Stroke Scale [NIHSS] score 0-5) from October 1, 2016, to December 31, 2017. Patient- and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. Primary outcomes included excellent discharge disposition (discharge to home without assistance); poor discharge disposition (discharge to facility or death); in-hospital mortality; and radiological intracranial hemorrhage.

RESULTS

Among 179 710 acute ischemic stroke admissions with recorded NIHSS during the 15-month study period, 103 765 (57.7%) had mild strokes (47.3% women; median age, 69 [interquartile range, 59-79] years; median NIHSS score of 2 [interquartile range, 1-4]). Considering reperfusion therapies among strokes with documented NIHSS, mild deficit hospitalizations accounted for 40.0% of IVT and 10.7% of mechanical thrombectomy procedures. Characteristics associated with IVT and with mechanical thrombectomy utilization were younger age, absence of diabetes, higher NIHSS score, larger/teaching hospital status, and Western US region. Excellent discharge outcome occurred in 48.2% of all mild strokes, and in multivariable analysis, was associated with younger age, male sex, White race, lower NIHSS score, absence of diabetes, heart failure, and kidney disease, and IVT use. IVT was associated with increased likelihood of excellent outcome (odds ratio, 1.90 [95% CI, 1.71-2.13], <0.001) despite an increased risk of intracranial hemorrhage (odds ratio, 1.41 [95% CI, 1.09-1.83], <0.001).

CONCLUSIONS

In national US practice, more than one-half of acute ischemic stroke hospitalizations had mild deficits, accounting for 4 of every 10 IVT and 1 of every 10 mechanical thrombectomy treatments, and IVT use was associated with increased discharge to home despite increased intracranial hemorrhage.

摘要

背景与目的

超过一半的急性缺血性脑卒中患者存在轻度神经功能缺损;然而,常规实践中再灌注治疗的频率和结果尚未明确。

方法

对 2016 年 10 月 1 日至 2017 年 12 月 31 日期间因急性缺血性脑卒中且轻度神经功能缺损(美国国立卫生研究院卒中量表 [NIHSS]评分 0-5 分)住院的美国国家住院患者样本进行分析。分析了与再灌注治疗使用和结局相关的患者和医院特征。主要结局包括出院时的良好转归(无需辅助即可出院回家);不良转归(出院至医疗机构或死亡);住院死亡率;以及影像学颅内出血。

结果

在 15 个月的研究期间,179710 例记录有 NIHSS 的急性缺血性脑卒中住院患者中,103765 例(47.3%为女性;中位年龄 69 [四分位间距,59-79] 岁;中位 NIHSS 评分为 2 [四分位间距,1-4])存在轻度脑卒中。在有 NIHSS 记录的脑卒中患者中,考虑再灌注治疗,轻度缺陷住院患者占 IVT 的 40.0%和机械取栓术的 10.7%。与 IVT 和机械取栓术应用相关的特征是年龄较小、无糖尿病、NIHSS 评分较高、较大/教学医院地位以及美国西部地区。所有轻度脑卒中患者中,出院结局良好的比例为 48.2%,多变量分析显示,年龄较小、男性、白人、NIHSS 评分较低、无糖尿病、心力衰竭和肾脏疾病以及 IVT 应用与出院结局良好相关。尽管颅内出血风险增加(比值比 1.41 [95%CI,1.09-1.83],<0.001),但 IVT 与更好的结局(比值比 1.90 [95%CI,1.71-2.13],<0.001)相关。

结论

在美国的常规实践中,超过一半的急性缺血性脑卒中住院患者存在轻度神经功能缺损,占每 10 例 IVT 和每 10 例机械取栓术治疗的 4 例,IVT 的应用与出院回家的比例增加相关,尽管颅内出血的风险增加。

相似文献

1
Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States.美国轻度缺血性卒中的再灌注治疗频率和结局。
Stroke. 2020 Nov;51(11):3241-3249. doi: 10.1161/STROKEAHA.120.030898. Epub 2020 Oct 21.
2
Distributional Validity and Prognostic Power of the National Institutes of Health Stroke Scale in US Administrative Claims Data.国立卫生研究院卒中量表在美国行政索赔数据中的分布有效性和预后能力。
JAMA Neurol. 2020 May 1;77(5):606-612. doi: 10.1001/jamaneurol.2019.5061.
3
Comparison of the Clinical Outcomes Between Reperfusion and Non-Reperfusion Therapy in Elderly Patients with Acute Ischemic Stroke.比较老年急性缺血性脑卒中患者再灌注与非再灌注治疗的临床结局。
Clin Interv Aging. 2024 Jul 10;19:1247-1258. doi: 10.2147/CIA.S464010. eCollection 2024.
4
Ischemic stroke and reperfusion therapies in diabetic patients.糖尿病患者的缺血性脑卒中与再灌注治疗。
Neurol Sci. 2022 Jul;43(7):4335-4348. doi: 10.1007/s10072-022-05935-x. Epub 2022 Feb 11.
5
Blood Pressure and Hospital Discharge Outcomes in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy.血压与接受再灌注治疗的急性缺血性脑卒中患者的出院结局。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105211. doi: 10.1016/j.jstrokecerebrovasdis.2020.105211. Epub 2020 Aug 7.
6
National trends and outcomes of hospital presentation mode for endovascular stroke treatment in the U.S.美国血管内卒中治疗中医院就诊模式的国家趋势和结果
J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107951. doi: 10.1016/j.jstrokecerebrovasdis.2024.107951. Epub 2024 Aug 21.
7
Validation of a neurovascular comorbidity index for risk adjustment of comorbid conditions among ischemic stroke patients receiving reperfusion treatment.验证神经血管合并症指数在调整接受再灌注治疗的缺血性脑卒中患者合并症风险中的作用。
J Stroke Cerebrovasc Dis. 2023 Aug;32(8):107189. doi: 10.1016/j.jstrokecerebrovasdis.2023.107189. Epub 2023 Jun 20.
8
Impact of transfer status on hospitalization cost and discharge disposition for acute ischemic stroke across the US.美国急性缺血性卒中患者转诊状态对住院费用及出院处置的影响
J Neurosurg. 2016 May;124(5):1228-37. doi: 10.3171/2015.4.JNS141631. Epub 2015 Oct 9.
9
Time from I.V. Thrombolysis to Thrombectomy and Outcome in Acute Ischemic Stroke.静脉溶栓至血管内取栓时间与急性缺血性脑卒中结局的关系。
Ann Neurol. 2021 Mar;89(3):511-519. doi: 10.1002/ana.25978. Epub 2020 Dec 15.
10
National Trends in Utilization and Outcome of Endovascular Thrombectomy for Acute Ischemic Stroke in Elderly.老年急性缺血性脑卒中血管内血栓切除术的利用和结局的国家趋势。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105505. doi: 10.1016/j.jstrokecerebrovasdis.2020.105505. Epub 2020 Dec 1.

引用本文的文献

1
Variations in Methodological Approaches to Measuring Health Inequalities and Inequities: A Scoping Review of Acute Stroke Pathways.衡量健康不平等和不公平的方法学途径的差异:急性卒中路径的范围综述
Healthcare (Basel). 2025 Jun 12;13(12):1410. doi: 10.3390/healthcare13121410.
2
Early neurological deterioration in patients with minor stroke: A single-center study conducted in Vietnam.轻度中风患者的早期神经功能恶化:在越南进行的一项单中心研究。
PLoS One. 2025 May 19;20(5):e0323700. doi: 10.1371/journal.pone.0323700. eCollection 2025.
3
Thrombolysis for acute ischaemic stroke: development and update.
急性缺血性卒中的溶栓治疗:进展与更新
Brain Commun. 2025 Apr 28;7(3):fcaf164. doi: 10.1093/braincomms/fcaf164. eCollection 2025.
4
[Multicenter Study on the Frequency of Large Vessel Occlusion in Patients with Minor Stroke].[小卒中患者大血管闭塞发生率的多中心研究]
Rev Neurol. 2025 Apr 3;80(3):33477. doi: 10.31083/RN33477.
5
Efficacy of intravenous thrombolysis in patients with mild acute ischemic stroke and large vessel occlusion with different hypoperfusion volumes.轻度急性缺血性卒中合并不同低灌注量的大血管闭塞患者静脉溶栓的疗效
Neurol Sci. 2025 Mar 19. doi: 10.1007/s10072-025-08109-7.
6
Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management.接受再灌注治疗的轻度中风患者的患病率及预后:一项荟萃分析及关于最佳管理的SAFE建议
J Cent Nerv Syst Dis. 2025 Feb 12;17:11795735251314881. doi: 10.1177/11795735251314881. eCollection 2025.
7
Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients.静脉溶栓的安全性和有效性:对93057例轻度中风患者的系统评价和荟萃分析。
BMC Neurol. 2025 Jan 22;25(1):33. doi: 10.1186/s12883-024-04000-8.
8
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis.抗血小板治疗与静脉溶栓治疗轻度急性缺血性卒中的比较:一项实时系统评价和荟萃分析。
Stroke Vasc Neurol. 2025 Apr 29;10(2):e003097. doi: 10.1136/svn-2024-003097.
9
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA.美国急性缺血性中风治疗在可及性和治疗结果方面的种族差异。
Stroke Vasc Neurol. 2025 Feb 25;10(1):65-70. doi: 10.1136/svn-2023-003051.
10
Comparison of Dual Antiplatelet Therapies for Minor, Nondisabling, Acute Ischemic Stroke: A Bayesian Network Meta-Analysis.双联抗血小板治疗急性非致残性缺血性卒中小发作的比较:贝叶斯网状Meta 分析。
JAMA Netw Open. 2024 May 1;7(5):e2411735. doi: 10.1001/jamanetworkopen.2024.11735.